Literature DB >> 23599638

Alcohol consumption and fatty liver disease.

Ren-Nan Feng, Guo-Dong Sun, Yan Zhao, Fu-Chuan Guo, Chang-Hao Sun.   

Abstract

Hamaguchi et al recently reported some interesting observations on alcohol consumption and risk of fatty liver disease from a large population. However, we feel that it might be necessary to discuss some concerns in this study. As the alcohol consumption categorization was defined by the same criteria in both men and women, which might affect their results. As another factor is soft drinks consumption. It has been proved that soft drinks, especially fructose, contributes to the development of obesity, diabetes, metabolic syndrome, and nonalcoholic fatty liver disease. However, this confounding factor was not adjusted or discussed in this article. The third is the genetic background, for some genetic factors are related with the development of fatty liver disease, which was also not considered yet.

Entities:  

Keywords:  Alcohol; Diabetes; Fatty liver disease; Metabolic syndrome; Obesity

Mesh:

Year:  2013        PMID: 23599638      PMCID: PMC3623996          DOI: 10.3748/wjg.v19.i13.2129

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Malgorzata Lawniczak; Joanna Miezynska-Kurtycz; Jan Lubinski
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 2.  Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.

Authors:  Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

3.  Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.

Authors:  Masahide Hamaguchi; Takao Kojima; Akihiro Ohbora; Noriyuki Takeda; Michiaki Fukui; Takahiro Kato
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

Review 4.  Genetically modified mouse models for the study of nonalcoholic fatty liver disease.

Authors:  Perumal Nagarajan; M Jerald Mahesh Kumar; Ramasamy Venkatesan; Subeer S Majundar; Ramesh C Juyal
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

5.  Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.

Authors:  Johannes-W Rey; Andrea Noetel; Aline Hardt; Ali Canbay; Hakan Alakus; Axel Zur Hausen; Hans-Peter Dienes; Uta Drebber; Margarete Odenthal
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

6.  Soft drinks consumption and nonalcoholic fatty liver disease.

Authors:  William Nseir; Fares Nassar; Nimer Assy
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

7.  Protective effect of alcohol consumption for fatty liver but not metabolic syndrome.

Authors:  Masahide Hamaguchi; Takao Kojima; Akihiro Ohbora; Noriyuki Takeda; Michiaki Fukui; Takahiro Kato
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

8.  PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

  8 in total
  1 in total

1.  Favorable effect of modest alcohol consumption to fatty liver disease.

Authors:  Masahide Hamaguchi; Takao Kojima
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.